Indivior Pharmaceuticals ($INDV) Insider Trading & Smart Money Activity
Indivior Pharmaceuticals, Inc. ($INDV) has 4 insider trades and 1 analyst rating on file. In the last 12 months on the open market, no insider bought and 1 insider sold ($1.41M), net -$1.41M.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 1
- Net insider $ (12 mo)
- -$1.41M
- Congress trades (12 mo)
- 0
- 13F moves on file
- 0
- Analyst ratings on file
- 1
INDV insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 2 · $1.41M | 0 / 0 | 0 / 0 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All INDV insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Joseph CiaffoniChief Executive Officer | Sell (Tax withholding) | 612.55K sh | $23.47M | +7.7% | +5.6% | — | ||||
| Insider | Joseph CiaffoniChief Executive Officer | Buy (Option exercise) | 1.27M sh | +7.7% | +5.6% | — | |||||
| Analyst | Barclays | Reiterates to buy | PT $46 | +7.8% | +2.1% | Read | |||||
| Insider | Christian HeidbrederChief Scientific Officer | Sell (Open-market sale) 10b5-1 | 18.59K sh | $707.38K | +0.4% | +5.5% | — | ||||
| Insider | Christian HeidbrederChief Scientific Officer | Sell (Open-market sale) 10b5-1 | 18.59K sh | $707.38K | +0.4% | +5.5% | — |
1W / 1M / 6M = how INDV moved from the trade or filing date.
Insider trading in INDV: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Joseph Ciaffoni | Chief Executive Officer | 2 | — | Jun 22, 2026 | |
| Christian Heidbreder | Chief Scientific Officer | 2 | -$1.41M | Jun 11, 2026 |
Analyst ratings on INDV
| Date | Firm | Action | Rating | Price target | 1W | 1M | 6M | Story |
|---|---|---|---|---|---|---|---|---|
| Barclays | Reiterates | buy | $46 | +7.8% | +2.1% | Read |
Frequently asked questions
Are INDV insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 1 insider made 2 open-market sales worth $1.41M, a net -$1.41M.
What is the latest insider trade in INDV?
Joseph Ciaffoni, Chief Executive Officer filed a sell (tax withholding) of 612.55K sh worth $23.47M on Jun 22, 2026.
Other drug manufacturers - specialty & generic stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.